Diffusion basis spectrum imaging (DBSI) has successfully distinguished co-existing pathological processes in CNS diseases, such as multiple sclerosis (MS). The aim of our study was to determine the feasibility of DBSI in MS patients at 7T and to investigate the underlying pathological substrates of different lesion types and normal appearing white matter (NAWM).
For the first time, we proved the feasibility of DBSI at 7T, validating the specificity of the different metrics to diverse pathological substrates. Additionally, we employed DBSI metrics to characterize focal and diffuse tissue damage in different MS phenotypes, confirming their utility as biomarkers of tissue-specific microstructural damage.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords